Tags

Type your tag names separated by a space and hit enter

The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries?
Vaccine. 2014 Feb 12; 32(8):904-8.V

Abstract

Dengue results in as many as 390 million infections annually and causes significant morbidity. A number of efforts are underway to develop vaccines against dengue. The public sector is undertaking efforts to create an enabling environment for vaccine introduction. Recent work by Brooks et al. provides a framework for analyzing which efforts should be undertaken before licensure. They conclude that actions before licensure are required to eliminate the decade or more it normally takes to introduce new vaccines into developing countries. We apply their methodology to dengue and identify a number of critical areas where public sector actions before licensure can greatly accelerate vaccine uptake.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Mahoney R
Global Health Consultant, Sedona, AZ 86336, United States. Electronic address: richardtmahoney@gmail.com.

MeSH

DengueDengue VaccinesDeveloping CountriesHealth PolicyImmunization ProgramsLicensurePublic Sector

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

24397903

Citation

Mahoney, Richard. "The Introduction of New Vaccines Into Developing Countries. V: Will We Lose a Decade or More in the Introduction of Dengue Vaccines to Developing Countries?" Vaccine, vol. 32, no. 8, 2014, pp. 904-8.
Mahoney R. The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries? Vaccine. 2014;32(8):904-8.
Mahoney, R. (2014). The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries? Vaccine, 32(8), 904-8. https://doi.org/10.1016/j.vaccine.2013.12.061
Mahoney R. The Introduction of New Vaccines Into Developing Countries. V: Will We Lose a Decade or More in the Introduction of Dengue Vaccines to Developing Countries. Vaccine. 2014 Feb 12;32(8):904-8. PubMed PMID: 24397903.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries? A1 - Mahoney,Richard, Y1 - 2014/01/05/ PY - 2013/11/06/received PY - 2013/12/11/revised PY - 2013/12/18/accepted PY - 2014/1/9/entrez PY - 2014/1/9/pubmed PY - 2014/8/16/medline KW - Dengue KW - Introduction KW - Prelicensure KW - Vaccines SP - 904 EP - 8 JF - Vaccine JO - Vaccine VL - 32 IS - 8 N2 - Dengue results in as many as 390 million infections annually and causes significant morbidity. A number of efforts are underway to develop vaccines against dengue. The public sector is undertaking efforts to create an enabling environment for vaccine introduction. Recent work by Brooks et al. provides a framework for analyzing which efforts should be undertaken before licensure. They conclude that actions before licensure are required to eliminate the decade or more it normally takes to introduce new vaccines into developing countries. We apply their methodology to dengue and identify a number of critical areas where public sector actions before licensure can greatly accelerate vaccine uptake. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/24397903/The_introduction_of_new_vaccines_into_developing_countries__V:_Will_we_lose_a_decade_or_more_in_the_introduction_of_dengue_vaccines_to_developing_countries L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(13)01804-5 DB - PRIME DP - Unbound Medicine ER -